Furthermore, HMGB1 has been found to promote osteoclast formation by binding to a receptor activator of NF-κB ligand, thus inducing additional destructive effects on the joint tissues of RA patients (Zhou et al., 2008). Here, HMGB1 is linked to rheumatoid arthritis.